E16.9 ICD-10-CM Code: Disorder of pancreatic internal secretion, unspecified
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)
E16.9
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceDisorder of pancreatic internal secretion, unspecified
A disorder of pancreatic hormone production or regulation, but the specific type is not identified.

Buddy Insight
E16.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
N/A—
Not mapped
ACA/HHS
N/A—
Not mapped
ESRD/PACE
N/A—
Not mapped
RXHCC
MappedHCC 66
RAF 0.245
Code Book Path
Inclusion Terms
Official- Islet-cell hyperplasia NOS
- Pancreatic endocrine cell hyperplasia NOS
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for E16.9 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for E16.9 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for E16.9 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for E16.9 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for E16.9 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for E16.9 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E16.9 an HCC code?
E16.9 is not in the CMS-HCC V28 or V24 community payment model, but it does map to Pancreatic Disease and Disorders under the Part D RxHCC model.
- Code
- E16.9
- Description
- Disorder of pancreatic internal secretion, unspecified
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work E16.9 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for E16.9
For E16.9 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed E16.9 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E16.9 is the ICD-10-CM diagnosis code for disorder of pancreatic internal secretion, unspecified. A disorder of pancreatic hormone production or regulation, but the specific type is not identified. E16.9 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering other disorders of glucose regulation and pancreatic internal secretion (e15-e16).
E16.9 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
This code does not map to a CMS-HCC V28 payment category. Capture depends on documentation that supports the diagnosis; verify the HCC assignment against the current CMS mapping for the applicable payment year. Coders reviewing E16.9 should check whether additional documentation would support a more specific child code in the same hierarchy that does map to a payment HCC, capturing the correct specificity is the highest-impact RAF improvement available within accurate coding.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for E16.9 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is an unspecified code; query the provider to identify the specific pancreatic endocrine disorder
- •Use only when the specific disorder cannot be determined from available documentation
Clinical Significance
E16.9 identifies unspecified disorder of pancreatic internal secretion. This nonspecific code indicates that a pancreatic endocrine dysfunction exists but has not been further characterized. It may be used during initial workup before a definitive diagnosis is established, but should be replaced with a more specific code once the condition is identified.
Documentation Requirements
- ✓Documentation should indicate suspected or confirmed pancreatic endocrine dysfunction.
- ✓Laboratory studies (insulin, glucagon, gastrin, or other pancreatic hormone levels) and clinical findings should be present.
- ✓The provider should be queried for additional specificity whenever possible.

